Silexion Therapeutics Ltd.(SLXN)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | Shirvan Mitchell CSO and CDO | Sale | -22,818 | -45.00%27,889 | $1.36 | $31,032 | View SEC filing |
1-1 of 1